We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
-3.96%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.3B
AUM Growth
-$438M
(-16%)
Cap. Flow
-$269M
Cap. Flow
% of AUM
-11.7%
Top 10 Holdings %
Top 10 Hldgs %
35.75%
Holding
1,125
New
22
Increased
279
Reduced
683
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$1.84M |
| 2 |
DoorDash
DASH
|
+$1.62M |
| 3 |
TSMC
TSM
|
+$1.62M |
| 4 |
Salesforce
CRM
|
+$1.55M |
| 5 |
JD.com
JD
|
+$1.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$40.2M |
| 2 |
Apple
AAPL
|
+$17.2M |
| 3 |
Broadcom
AVGO
|
+$16.1M |
| 4 |
Microsoft
MSFT
|
+$14.4M |
| 5 |
Amazon
AMZN
|
+$8.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.42% |
| 2 | Consumer Discretionary | 11.82% |
| 3 | Communication Services | 10.93% |
| 4 | Healthcare | 10.61% |
| 5 | Financials | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Cushman & Wakefield Ltd
CWK
$2.98B
| $103K | ﹤0.01% |
10,127
-3,334
| -25% | -$40.5K |
|
|
DFTX
952
Definium Therapeutics
DFTX
$5.73B
| $102K | ﹤0.01% |
17,509
+5,216
| +42% | +$37.4K |
|
|
EXK
953
Endeavour Silver
EXK
$2.32B
| $96.5K | ﹤0.01% |
22,609
+6,179
| +38% | +$24.8K |
|
954
Gerdau
GGB
$9.44B
| $93.7K | ﹤0.01% |
33,003
+6,664
| +25% | +$19.5K |
|
|
HBI
955
DELISTED
Hanesbrands
HBI
| $93.1K | ﹤0.01% |
16,131
-3,495
| -18% | -$24.5K |
|
956
Omeros
OMER
$709M
| $93K | ﹤0.01% |
+11,308
| New | +$99.8K |
|
|
MPT
957
Medical Properties Trust
MPT
$2.89B
| $92.7K | ﹤0.01% |
15,371
-6,366
| -29% | -$32.2K |
|
958
Oric Pharmaceuticals
ORIC
$1.25B
| $91.9K | ﹤0.01% |
16,469
+5,651
| +52% | +$49.4K |
|
959
Payoneer
PAYO
$2.41B
| $90.2K | ﹤0.01% |
12,333
-1,999
| -14% | -$18.6K |
|
960
Cullinan Oncology
CGEM
$1.05B
| $89.7K | ﹤0.01% |
11,846
-5,773
| -33% | -$55.4K |
|
961
Lufax Holding
LU
$1.2B
| $87.6K | ﹤0.01% |
29,489
+2,682
| +10% | +$7.44K |
|
962
CleanSpark
CLSK
$3.73B
| $87.6K | ﹤0.01% |
+13,031
| New | +$123K |
|
963
Akebia Therapeutics
AKBA
$327M
| $86.3K | ﹤0.01% |
44,922
+7,252
| +19% | +$14.8K |
|
964
Cleveland-Cliffs
CLF
$6.81B
| $86.1K | ﹤0.01% |
10,475
-597
| -5% | -$6.07K |
|
965
Stoke Therapeutics
STOK
$1.82B
| $85.7K | ﹤0.01% |
12,882
-266
| -2% | -$2.48K |
|
966
CEMIG Preferred Shares
CIG
$6.09B
| $83K | ﹤0.01% |
47,139
+10,981
| +30% | +$20.4K |
|
967
CorMedix
CRMD
$617M
| $76.9K | ﹤0.01% |
12,480
-5,498
| -31% | -$56.9K |
|
968
NovaGold Resources
NG
$2.6B
| $74.7K | ﹤0.01% |
+25,584
| New | +$82.3K |
|
|
ESPR
969
DELISTED
Esperion Therapeutics
ESPR
| $73.6K | ﹤0.01% |
51,113
+5,429
| +12% | +$10K |
|
970
RLX Technology
RLX
$2.48B
| $71.5K | ﹤0.01% |
38,021
+2,533
| +7% | +$5.62K |
|
971
Nuvation Bio
NUVB
$2.24B
| $71.2K | ﹤0.01% |
40,474
+9,195
| +29% | +$20.9K |
|
972
Sana Biotechnology
SANA
$885M
| $69K | ﹤0.01% |
41,082
-19,494
| -32% | -$54.5K |
|
973
EyePoint Inc
EYPT
$1.02B
| $67.3K | ﹤0.01% |
12,425
-1,321
| -10% | -$9.24K |
|
974
Arbutus Biopharma
ABUS
$865M
| $66.7K | ﹤0.01% |
19,115
-11,113
| -37% | -$37.1K |
|
975
Newell Brands
NWL
$2.16B
| $66K | ﹤0.01% |
10,650
-4,411
| -29% | -$35.4K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Profund Advisors held 1,125 positions worth $2.3B, down 16% from $2.74B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Profund Advisors withdrew a net $269M in Q1 2025, closing 141 positions and reducing 683 holdings. Its most notable exit was Pacific Premier Bancorp, an estimated $422K position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Profund Advisors opened a new position in Guidewire Software worth $383K.
- Profund Advisors's largest Q1 2025 buy was Guidewire Software: 2,042 shares worth $383K.
- Profund Advisors added most to Arista Networks in Q1 2025, an estimated $1.84M increase.
- Profund Advisors's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $40.2M.
- Profund Advisors fully exited Pacific Premier Bancorp in Q1 2025, selling an estimated $422K.
- Profund Advisors's ten largest holdings make up 36% of its $2.3B portfolio in Q1 2025.
- Profund Advisors opened 22 new positions and closed 141 in Q1 2025.
- Profund Advisors's portfolio value fell 16% quarter-over-quarter to $2.3B.
Based on Profund Advisors's 13F filing for Q1 2025, filed 8 May 2025.